BioNTech — Deal History & Benchmarks
Total Deals
4
Across 1 therapeutic area
Total Deal Value
$9.3B
Cumulative transaction value
Most Active Year
2024
3 deals closed
Primary TA
Oncology
100% of deal activity
Market Analysis
BioNTech has been involved in 4 transactions totaling $9.3B across Oncology. As both a licensor and licensee, they have demonstrated a preference for licensing partnerships.
PRO
Full Benchmark Analysis
Complete deal term ranges, comparable transactions, and negotiation insights.
We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.
or
Unlock Everything — $299/mo Pro7-day money-back guarantee · Cancel anytime
Customize these benchmarks for your asset
Adjust phase, modality, competitive position, and 10+ other parameters.
Frequently Asked Questions
How many deals has BioNTech done?
BioNTech has completed 4 verified transactions tracked in our database, spanning from 2024 to 2025. These deals have a combined value of $9.3B.
PRO
Full Benchmark Analysis
Complete deal term ranges, comparable transactions, and negotiation insights.
We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.
or
Unlock Everything — $299/mo Pro7-day money-back guarantee · Cancel anytime
Ready to Calculate Your Deal Terms?
Get instant, customized benchmarks based on real market data from 600+ biopharma licensing deals.
Start Calculating